14-87993044-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 5 ACMG points: 6P and 1B. PM1PM2PP2PP5BP4

The NM_000153.4(GALC):​c.121G>A​(p.Gly41Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G41A) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

GALC
NM_000153.4 missense

Scores

2
4
13

Clinical Significance

Pathogenic no assertion criteria provided P:1

Conservation

PhyloP100: 1.73

Publications

17 publications found
Variant links:
Genes affected
GALC (HGNC:4115): (galactosylceramidase) This gene encodes a lysosomal protein which hydrolyzes the galactose ester bonds of galactosylceramide, galactosylsphingosine, lactosylceramide, and monogalactosyldiglyceride. Mutations in this gene have been associated with Krabbe disease, also known as globoid cell leukodystrophy. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
GALC Gene-Disease associations (from GenCC):
  • Krabbe disease
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Myriad Women’s Health, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 5 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 13 uncertain in NM_000153.4
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 94 curated pathogenic missense variants (we use a threshold of 10). The gene has 16 curated benign missense variants. Gene score misZ: 0.18582 (below the threshold of 3.09). Trascript score misZ: -0.28853 (below the threshold of 3.09). GenCC associations: The gene is linked to Krabbe disease.
PP5
Variant 14-87993044-C-T is Pathogenic according to our data. Variant chr14-87993044-C-T is described in ClinVar as Pathogenic. ClinVar VariationId is 30621.Status of the report is no_assertion_criteria_provided, 0 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.26462346). . Strength limited to SUPPORTING due to the PP5.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GALCNM_000153.4 linkc.121G>A p.Gly41Ser missense_variant Exon 1 of 17 ENST00000261304.7 NP_000144.2 P54803-1A0A0A0MQV0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GALCENST00000261304.7 linkc.121G>A p.Gly41Ser missense_variant Exon 1 of 17 1 NM_000153.4 ENSP00000261304.2 P54803-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1404310
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
694604
African (AFR)
AF:
0.00
AC:
0
AN:
30940
American (AMR)
AF:
0.00
AC:
0
AN:
37708
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24846
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36136
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80472
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
45400
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4762
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1085944
Other (OTH)
AF:
0.00
AC:
0
AN:
58102
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Galactosylceramide beta-galactosidase deficiency Pathogenic:1
Nov 01, 2011
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Uncertain
0.10
D
BayesDel_noAF
Benign
-0.090
CADD
Benign
22
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.49
T;.
Eigen
Benign
-0.75
Eigen_PC
Benign
-0.66
FATHMM_MKL
Benign
0.45
N
LIST_S2
Benign
0.71
T;T
M_CAP
Pathogenic
0.42
D
MetaRNN
Benign
0.26
T;T
MetaSVM
Uncertain
-0.26
T
MutationAssessor
Benign
0.95
L;L
PhyloP100
1.7
PrimateAI
Pathogenic
0.83
D
PROVEAN
Benign
0.49
N;N
REVEL
Benign
0.23
Sift
Benign
0.40
T;T
Sift4G
Benign
0.69
T;T
Polyphen
0.56
P;.
Vest4
0.34
MutPred
0.65
Gain of glycosylation at G41 (P = 0.0252);Gain of glycosylation at G41 (P = 0.0252);
MVP
0.83
MPC
0.13
ClinPred
0.19
T
GERP RS
1.3
PromoterAI
-0.036
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.039
gMVP
0.64
Mutation Taster
=27/73
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs387906955; hg19: chr14-88459388; API